Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tofacitinib 5 mg BID
DRUG
2 trials
Sponsors
Pfizer
, Shanghai Zhongshan Hospital
Conditions
Glucocorticoid Resistant ICIs-related Myocarditis
Psoriatic Arthritis
Phase 2
The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis
Not yet recruiting
NCT06393972
Shanghai Zhongshan Hospital
Glucocorticoid Resistant ICIs-related Myocarditis
Start: 2024-07-01
End: 2026-11-30
Target: 25
Updated: 2024-05-01
Phase 3
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Completed
NCT01877668
Pfizer
Psoriatic Arthritis
Start: 2014-01-20
End: 2015-12-18
Updated: 2017-07-06
Related Papers
Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials.
2025-10-28
Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies
RMD Open
2025-05-01
Long-term tofacitinib efficacy and safety in psoriatic arthritis with or without prior biologic DMARD exposure: a post hoc analysis
Rheumatology Advances in Practice
2025-01-01
Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis.
2024-12-19
2 citations
Exposure–Response Analysis of Tofacitinib in Active Psoriatic Arthritis: Results from Two Phase 3 Studies
The Journal of Clinical Pharmacology
2024-10-25
2 citations
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status.
2024-09-25
2 citations
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data.
2024-05-02
5 citations
Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies.
2023-08-22
2 citations
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance.
2023-03-17
81 citations
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
RMD Open
2023-03-01
19 citations
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study
RMD Open
2023-01-01
22 citations
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
Therapeutic Advances in Musculoskeletal Disease
2023-01-01
19 citations
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.
2022-12-17
5 citations
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies
Seminars in Arthritis and Rheumatism
2022-11-13
8 citations
Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation Analysis.
2022-09-08
3 citations
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
RMD Open
2022-09-01
20 citations
Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies.
2022-09-01
1 citations
Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
Journal of Dermatological Treatment
2022-04-06
2 citations
Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
Arthritis Research & Therapy
2022-02-09
8 citations
Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
Rheumatology and Therapy
2021-12-17
2 citations
22 more papers not shown